Research
Hormonal
Metformin treatment increases the abundance of Akkermansia muciniphila, contributing to its metabolic benefits.
If you take Metformin for Type 2 Diabetes, it may be helping your gut health by increasing Akkermansia muciniphila. This is one of the mechanisms by which the drug improves metabolic function.
ModerateSupportsMEDIUM confidence
Metformin increases A muciniphila concentrations
Why this rating
Supported by multiple studies, but the causal link between increased A. muciniphila and metformin's efficacy is still being elucidated.
Source
Microbiota and diabetes: an evolving relationship
Herbert Tilg et al. · Gut · 2014
DOI 10.1136/gutjnl-2014-306928
narrative_reviewCited 830×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →